Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

High rate of POP recurrence associated with vaginal mesh

Posted in Vaginal Mesh

It is estimated that 300,000 pelvic organ prolapse related surgeries are performed in the United States every year.  Pelvic organ prolapse is a global wide health issue for women.  High failure rates are seen with anterior surgical repair of cystocele or anterior wall prolapse.  These procedures may constrict and impair vaginal anatomy.  Some doctors recommend that paravaginal repairs should be performed abdominally or laparoscopically for providing sounder anatomic support.  New methods for treating anterior vaginal prolapse have been created, showing to have higher cure rates than traditional methods.  These new methods require complex dissections and surgical techniques which may come with their own complications.  Author Robert D. Moore, from the International Urogynecological Association, wrote an article called “Prospective Multicenter Trial assessing type 1, Polypropylene Mesh placed Via Transobuturator Route for the Treatment of Anterior Vaginal Prolapse”, where he states that “The use of synthetic mesh is considered the gold standard for treatment of vault prolapse abdominally with sacral colpopexy [4]. More recently, grafts have been used vaginally to treat prolapse, including the anterior compartment, in attempts to try to reproduce the success that mesh has been shown to have with sacral colpopexy. Various methods have been described and most have been shown to have higher cure rates than traditional repairs.”

A review written by A. Cochrane in 2008, supports the use of mesh graft in the anterior compartments.  The review reported a higher rate of recurrent prolapse after anterior colporrhaphy than after mesh repair.  Robert D. Moore continues to explain “The transobturator space has been shown to be a safe space for the placement of tension-free tape slings for the treatment of stress urinary incontinence and has simplified the technique of this procedure [7, 8]. The space has also been more recently used to assist with anterior wall mesh placement. De Tayrac was the first to describe its use in cystocele repair by securing the anterior arms of a tension free graft; however, no apical attachment of the graft was described.”  The Perigee System, a minimally invasive treatment option, was created to place an anterior wall graft for cystocele repair.

Some studies suggest an 18-month cure rate for 93.5 percent of the patient’s using this procedure, which is OK but not sufficient, given that around 50 percent of women who have multiple children may develop pelvic organ prolapse.

In light of all the research showing the danger of transvaginal mesh, many manufacturers of TVM products have failed to notify customers of the risks associated with their products.  And as such, transvaginal mesh lawsuits have been filed around the world.

If you or a loved one used transvaginal mesh and experienced a complication of vaginal mesh or suffered TVM recurrence of pelvic organ prolapse, you may be eligible to file a transvaginal mesh lawsuit. For more information or a free, no-obligation case consultation, contact our team of transvaginal mesh lawyers at the information provided below.

(855) 452-5529

justinian@dangerousdrugs.us

Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have any questions about Transvaginal Mesh.